Acyline

Star0

DB11906InvestigationalSmall molecule

Acyline has been investigated for the prevention and treatment of Hypogonadism and Contraception.

Mechanism: Pharmacologically active on Gonadotropin-releasing hormone receptor
Curator reviewed
Formula / weight: C₈₀H₁₀₂ClN₁₅O₁₄ · 1533.24 g/mol (avg)
Code names: MER-104

Resolves to

Compound

UNIIS3439D3B35CAS170157-13-8ChEMBLCHEMBL262747PubChem16137348

Structure

InChIKeyZWNUQDJANZGVFO-YHSALVGYSA-NSMILES

CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(C)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(C)=O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O

Targets

P30968GNRHR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

12Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Acyline, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account